Syngenesis Chemscience Pvt. Ltd. Company Profile

Background

Company Overview

Syngenesis Chemscience Pvt. Ltd. is a pharmaceutical and specialty chemicals manufacturer established on March 22, 2017. The company's name combines "SYN," meaning "same or similar," and "GENESIS," signifying "creation of novel things," reflecting its commitment to innovation in chemical sciences. Registered as a Private Limited Company under the Corporate Identification Number (CIN) U24110MH2017PTC292851, Syngenesis operates primarily in the pharmaceutical industry, focusing on the development and manufacturing of drug intermediates and active pharmaceutical ingredients (APIs).

Mission and Vision

Syngenesis aims to enhance clients' businesses by providing high-quality products and services through eco-friendly, cost-effective, and commercially viable processes for APIs and their intermediates. The company is dedicated to developing long-term customer relationships based on integrity, excellence, teamwork, entrepreneurial spirit, respect, care, and customer focus.

Industry Significance

With a team possessing over 20 years of experience in organic chemistry, Syngenesis has contributed to more than 30 patents and 20 international/national publications in the field of Organic and Medicinal Chemistry. The company has experience working with renowned pharmaceutical companies such as Lupin Limited, Teva Pharmaceutical Industries, and Glenmark Pharmaceuticals, as well as top research institutes like the Indian Institute of Technology (IIT-Mumbai) and the Department of Chemistry, Yeshwant Mahavidyalaya Research Centre, SRTM, Nanded.

Key Strategic Focus

Core Objectives

Syngenesis focuses on manufacturing basic chemicals, pharmaceutical drug intermediates, and APIs, emphasizing the development of eco-friendly, cost-effective, and commercially viable processes. The company aims to provide high-quality raw materials, specialty chemicals, and support for contract research and manufacturing services in organic, pharmaceutical, and medicinal chemistry.

Areas of Specialization

The company specializes in a wide range of therapeutic areas, including:

Anti-cancer (Oncology products)

Anti-HIV

Anti-bacterial

Anti-biotics

Anti-hepatitis

Anti-hypertensive

Anti-inflammatory

Anti-tuberculosis

Anti-diabetics

Anti-obesity

Anti-Parkinson’s

Anti-depressant

Anti-psychotic

Anti-viral

Anti-rheumatic

Diuretics

Key Technologies Utilized

Syngenesis employs state-of-the-art research and manufacturing facilities, utilizing advanced equipment such as:

Thermo-Scientific Fume Hoods

Buchi Rotavapor

UV Chamber

Chiller

Refrigerator

Weighing Balances (Micro and Kg scale)

Fluidized Bed Dryer (60 Kg capacity)

Blender (1000 Kg capacity)

Steam Boiler (300 Kg capacity)

Cooling Tower (16,000 Lit capacity)

Chilling Plant (10 TR capacity)

Scrubbers (SS, PP(FRP lined), MS(FRP lined))

DG Set (63 KVA)

DM Water Plant

Air Compressor & Oil Vacuum Pumps

Primary Markets Targeted

Syngenesis serves a global clientele, providing high-quality pharmaceutical drug intermediates and APIs to various pharmaceutical companies and national/international research institutes and organizations.

Financials and Funding

Specific details regarding Syngenesis Chemscience Pvt. Ltd.'s funding history, total funds raised, recent funding rounds, notable investors, and intended utilization of capital are not publicly disclosed.

Pipeline Development

While Syngenesis specializes in the development and manufacturing of a wide range of pharmaceutical drug intermediates and APIs, specific details about key pipeline candidates, stages of clinical trials or product development, target conditions, and relevant timelines for anticipated milestones are not publicly available.

Technological Platform and Innovation

Proprietary Technologies

Syngenesis focuses on developing eco-friendly, cost-effective, and commercially viable processes for APIs and their intermediates. The company emphasizes green and eco-friendly chemistry processes by reducing solid, organic, and aqueous wastes during process development and optimization.

Significant Scientific Methods

The company employs advanced scientific methodologies, including:

Full synthesis of drug substances

Custom process research and scale-up services

Development of milligram to kilogram scale production processes

Custom research tailored and optimized for specific customer needs

AI-Driven Capabilities

Specific information regarding AI-driven capabilities at Syngenesis Chemscience Pvt. Ltd. is not publicly disclosed.

Leadership Team

Key Executives

Dr. Yogesh Dadaji Pawar: Co-Founder & Director

Mrs. Shubhangi Yogesh Pawar: Director

Professional Backgrounds and Contributions

Dr. Yogesh Dadaji Pawar and Mrs. Shubhangi Yogesh Pawar lead a team with over 20 years of experience in organic chemistry. The team has strong research and scale-up experiences from renowned pharmaceutical companies like Lupin Limited, Teva Pharmaceutical Industries, and Glenmark Pharmaceuticals, as well as top research institutes such as the Indian Institute of Technology (IIT-Mumbai) and the Department of Chemistry, Yeshwant Mahavidyalaya Research Centre, SRTM, Nanded. The team holds more than 30 patents and 20 international/national publications in the field of Organic and Medicinal Chemistry.

Competitor Profile

Market Insights and Dynamics

The pharmaceutical industry is characterized by rapid innovation, stringent regulatory requirements, and a global demand for high-quality drug intermediates and APIs. Companies like Syngenesis Chemscience Pvt. Ltd. play a crucial role in the supply chain by providing essential components for pharmaceutical manufacturing.

Competitor Analysis

Specific details about Syngenesis's competitors are not publicly disclosed.

Strategic Collaborations and Partnerships

Information regarding significant collaborations, partnerships, or alliances that strengthen Syngenesis's market position, innovation capacity, or expand capabilities is not publicly available.

Operational Insights

Syngenesis Chemscience Pvt. Ltd. differentiates itself through its commitment to eco-friendly and cost-effective processes, advanced manufacturing facilities, and a highly experienced team. The company's focus on green chemistry and waste reduction during process development and optimization positions it as a responsible and innovative player in the pharmaceutical manufacturing sector.

Strategic Opportunities and Future Directions

While specific strategic opportunities and future directions are not publicly disclosed, Syngenesis's emphasis on eco-friendly processes, cost-effective solutions, and high-quality product offerings suggests potential growth in global markets seeking sustainable and reliable pharmaceutical manufacturing partners.